COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB VERSUS INFLIXIMAB FOR THE PATIENTS WITH RHEUMATOID ARTHRITIS IN KAZAKHSTAN

被引：1
|
作者：
Bektur, C. [1 ]
Kayir, F. [2 ]
Nurgozhin, T. [1 ]
机构：
[1] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan
[2] Nazarbayev Univ, Astana, Kazakhstan
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2607
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS37
引用
收藏
页码：A379 / A379
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS, IN COLOMBIA
    Gamboa, O.
    Barbosa, D.
    Parada, L.
    Latorre, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A563 - A563
  • [2] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Diamantopoulos, Alex
    Finckh, A.
    Huizinga, T.
    Sungher, D. K.
    Sawyer, L.
    Neto, D.
    Dejonckheere, F.
    [J]. PHARMACOECONOMICS, 2014, 32 (08) : 775 - 787
  • [3] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Alex Diamantopoulos
    A. Finckh
    T. Huizinga
    D. K. Sungher
    L. Sawyer
    D. Neto
    F. Dejonckheere
    [J]. PharmacoEconomics, 2014, 32 : 775 - 787
  • [4] Cost-effectiveness of infliximab for rheumatoid arthritis in Spain
    Wong, JB
    Ballina, J
    Fernandez-Sueiro, J
    Garcia-Vadillo, J
    Gonzalez-Fernandez, C
    Gonzalez-Crespo, M
    Gratacos, J
    Ivorra, J
    Navarro-Sarabia, F
    Tornero, J
    Casado, MA
    Fosbrook, L
    Pocovi, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 520 - 521
  • [5] ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS
    Alfonso-Cristancho, R.
    Serra, N.
    Aiello, E. C.
    Roa, C. N.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A126 - A127
  • [6] Cost effectiveness analysis of etanercept versus infliximab in the treatment of rheumatoid arthritis patients
    Malone, DC
    Ortmeier, BG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 353 - 353
  • [7] COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF INADEQUATELY RESPONDING RHEUMATOID ARTHRITIS PATIENTS
    Hansen, R. N.
    Best, J. H.
    Sullivan, S. D.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A161 - A161
  • [8] Cost-effectiveness analysis of etanercept versus infliximab and anakinra in the treatment of rheumatoid arthritis in italy.
    Leardini, G
    Ganguly, R
    Singh, A
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S460 - S461
  • [9] Cost-effectiveness of lifelong infliximab for rheumatoid arthritis in Portugal
    Wong, JB
    Branco, JC
    Cobrado, N
    Nero, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 360 - 360
  • [10] COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA
    Alfonso-Cristancho, R.
    Aiello, E. C.
    Roa, C. N.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
12345